Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness

Completed · Not applicable · Has a placebo group

Conditions studied: Cardiovascular Disease

In brief

The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.

Key facts

Study ID

NCT02180841

Run by

Penn State University

People needed

20

Starts

2014-03-01

Expected to finish

2015-12-01

Last updated by the study team

2023-08-21

Who can join

Age: 35 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and Female
• 35-60 years old,with
• Systolic blood pressure greater than 120 mm Hg
• Diastolic blood pressure greater than 80 mm Hg
• BMI within 18-39 kg/m2 ,
• non smokers with
• no inflammatory diseases and
• not taking medication for high cholesterol, blood pressure, or glucose control

You may not qualify if…

• Under 35 years of age or over 60 years old
• Systolic blood pressure <120 or Diastolic blood pressure <80
• smoker
• inflammatory disease
• BMI outside of 18-39kg/m2 range
• taking medication
• refusal to discontinue any other supplement use

Where it is running

• Penn State University — University Park, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.